⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9514161 | 0.87 | — | — | |
| SCHEMBL270529 | 0.84 | — | — | |
| SCHEMBL29240876 | 0.84 | FDPS (0.45) | — | |
| SCHEMBL3794316 | 0.79 | — | — | |
| SCHEMBL51362 | 0.79 | — | — | |
| SCHEMBL9864557 | 0.78 | — | — | |
| SCHEMBL271139 | 0.76 | — | — | |
| SCHEMBL2707317 | 0.76 | FDPS (0.48) | — | |
| SCHEMBL28746873 | 0.76 | FDPS (0.48) | — | |
| SCHEMBL27711141 | 0.76 | FDPS (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0426826-B1 | SUBSTITUTED ISOXAZOLIDINES AND ISOXAZOLINES | PHARMACIA AB (SE) | 1994-04-27 | — | — | EP | claimed |
| US-5212305-A | Cyclization and forming a carbon-nitrogen bond | KABI PHARMACIA AKTIBOLAG (SE) | 1993-05-18 | — | — | US | claimed |
| US-5155220-A | Simplified production of plaque inhibitor | KABI PHARMACIA AKTIEBOLAG (SE) | 1992-10-13 | — | — | US | claimed |
| EP-0426826-A1 | SUBSTITUTED ISOXAZOLIDINES AND ISOXAZOLINES. | PHARMACIA AB (SE) | 1991-05-15 | — | — | EP | claimed |
| WO-1990014342-A1 | SUBSTITUTED ISOXAZOLIDINES AND ISOXAZOLINES | PHARMACIA AB (SE) | 1990-11-29 | — | — | WO | claimed |
| EP-1219599-B1 | VITAMIN D DERIVATIVES HAVING SUBSTITUENTS AT THE 2 ALPHA-POSITION | TAKAYAMA HIROAKI (JP) | 2010-03-31 | — | — | EP | disclosed |
| EP-1103300-B1 | ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-6902654-B2 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-06-07 | — | — | US | disclosed |
| US-20050113349-A1 | 2-Alpha vitamin D derivatives having substituents | HIROAKI TAKAYAMA (JP) | 2005-05-26 | — | — | US | disclosed |
| US-20040108198-A1 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2004-06-10 | — | — | US | disclosed |
| EP-0947504-B1 | 16-ENE-VITAMIN D DERIVATIVES | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6555699-B2 | Antitumor and antirheumatic agents, high binding affinity | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-04-29 | — | — | US | disclosed |
| EP-1219599-A1 | VITAMIN D DERIVATIVES HAVING SUBSTITUENTS AT THE 2 ALPHA-POSITION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-20020032340-A1 | 16-ene-vitamin D derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-03-14 | — | — | US | disclosed |
| EP-1174424-A1 | 3-METHYLATED VITAMIN D DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-01-23 | — | — | EP | disclosed |
| US-6326503-B1 | ANTITUMOR AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-12-04 | — | — | US | disclosed |
| EP-1158297-A1 | METHOD FOR SCREENING COMPOUND HAVING AFFINITY FOR VITAMIN D RECEPTOR | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-11-28 | — | — | EP | disclosed |
| EP-1103300-A1 | ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-05-30 | — | — | EP | disclosed |
| US-6184398-B1 | ANTITUMOR AGENTS AND TREATMENT OF RHEUMATIC CONDITIONS; HIGH BINDING ABILITY TO VITAMIN D RECEPTORS AND WEAK HYPERCALCEMIC ACTIVITY; E.G.,1,3-DIHYDROXY-20-3-HYDROXY-3-METHYLBUTYLTHIO)-9,10-SECOPREGNA -5,7,10(19),16-TETRAENE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-02-06 | — | — | US | disclosed |
| EP-0947504-A1 | 16-ENE-VITAMIN D DERIVATIVES | Chugai Seiyaku Kabushiki Kaisha (JP) | 1999-10-06 | — | — | EP | disclosed |